The document is a Balliau valuation report on NXS ...hopefully the NXS website will have it in the next few daysI get them emailed to me from Ballieau
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025